Genecast (Beijing) Technology Co., Ltd. was established in November 2014 and is located in Health Zhigu (Beijing) Mobile Health Industry Park. With the second-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.
In March 2016, Genecast Technology's 1200m2 laboratory (Phase I) was completed. The laboratory is equipped with cutting-edge facilities and meets the standards of the China National Health and Family Planning Commission's high-throughput sequencing laboratory.
In June 2017, Genecast Laboratories (Phase II), which was established byGenecast Technology, is based on clinical molecular molecular genetics testing and is engaged in molecular biology medical testing related to tumors. Toprovide tumor patients and doctors with the results of accurate medical examinations related to tumors, and assist doctors to establish precise treatment plans for individualized tumors.
We Provide Precision Testings and Diagnostics Certified By Multiple International Professional Organizations.
In June 2017, Genecast Laboratories (Phase II), which was established by Genecast Technology, is based on clinical molecular molecular genetics testing and is engaged in molecular biology medical testingrelated to tumors. To provide tumor patients and doctors with the results of accurate medical examinations related to tumors, and assist doctors to establish precise treatment plans for individualizedtumors.
The laboratory construction area is more than 600 square meters, all of which are constructed in accordance with the requirements of ISO15189 and CAP certification. It has a complete quality management systemand a complete set of standardized operating procedures. In addition to the configuration of conventional molecular laboratory instruments, the newly introduced sequencer NovaSeq 6000 Sequencing System,Thermo King Fisher Flex automatic nucleic acid extractor, Hamilton Star automation platform, intelligent high-speed refrigerated centrifuge, gradient PCR instrument, vacuum centrifugation The instrument, themicro-drop digital PCR system, and the LIMS system that can realize the informationization process can realize more accurate clinically relevant tumor-related molecules and pathological detection.
With the second-generation sequencing technology and bioinformatics as the core, we are engaged in
non-invasive precision diagnosis and accompanying diagnosis of tumors, and provide individualized health guidance for patients.
Genecast Technology integrates R&D, production and medical testing, and independently develops a number of national and international invention patents and software copyrights. At present, Yihe Science and Technology and the Peking University Cancer Hospital, the Chinese Academy of Medical Sciences Cancer Hospital, the Eighth First Hospital of the Chinese People's Liberation Army, the Shanghai Jiaotong University School of Medicine, Ruijin Hospital and other hospitals to carry out joint research cooperation projects, through technological innovation and cooperation and sharing, provide Safe, precise, full coverage of individualized health guidance. At the same time, Yanhe Technology cooperates with a number of multinational companies in drug clinical trial genetic testing to jointly promote the development of new drugs.
Genecast Accompanied Every step of our calculations.